Rashtriya Chemicals and Fertilizers First Quarter 2026 Earnings: EPS: ₹0.99 (vs ₹0.20 in 1Q 2025)
Rashtriya Chemicals and Fertilizers (NSE:RCF) First Quarter 2026 Results
Key Financial Results
- Revenue: ₹34.1b (down 22% from 1Q 2025).
- Net income: ₹544.3m (up 404% from 1Q 2025).
- Profit margin: 1.6% (up from 0.2% in 1Q 2025). The increase in margin was driven by lower expenses.
- EPS: ₹0.99 (up from ₹0.20 in 1Q 2025).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Rashtriya Chemicals and Fertilizers shares are down 1.7% from a week ago.
Risk Analysis
It's necessary to consider the ever-present spectre of investment risk. We've identified 2 warning signs with Rashtriya Chemicals and Fertilizers (at least 1 which is potentially serious), and understanding these should be part of your investment process.
New: AI Stock Screener & Alerts
Our new AI Stock Screener scans the market every day to uncover opportunities.
• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies
Or build your own from over 50 metrics.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About NSEI:RCF
Rashtriya Chemicals and Fertilizers
Manufactures, markets, and sells fertilizers and industrial chemicals in India.
Average dividend payer with slight risk.
Market Insights
Weekly Picks

Cue Biopharma (NASDAQ: CUE): The Scientist Behind Xolair Just Gave Cue a Next-Generation Shot at the Same Multi-Billion-Dollar Market

AST SpaceMobile: The Boldest Direct-to-Cell Bet in Public Markets
Onto Innovation: The Advanced Packaging Chokepoint 51.3% undervalued intrinsic discount

Investment Analysis (May 2026)
Recently Updated Narratives

Making sense of 1.75 trillion IPO
SpaceX? Only Fast in - Fast out!

INDIAN OIL CORPORATION IS THE TITAN IN TRANSITION
Popular Narratives

Investment Analysis (May 2026)

Take-Two Interactive: The Calm Before the Storm NASDAQ: TTWO Last Price: $242.41 Date: May 15, 2026

Honeywell - The Demand-Side of the AI Infrastructure
Trending Discussion
